神経内分泌腫瘍治療の世界市場インサイト、2030年までの予測Global Neuroendocrine Tumor Treatment Market Insights, Forecast to 2030 神経内分泌腫瘍(NETs)は、内分泌(ホルモン)系および神経系の細胞から発生する新生物である。多くは良性であるが、一部は悪性である。NETは腸に発生することが最も多く、カルチノイド腫瘍と呼ばれることもある... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー神経内分泌腫瘍(NETs)は、内分泌(ホルモン)系および神経系の細胞から発生する新生物である。多くは良性であるが、一部は悪性である。NETは腸に発生することが最も多く、カルチノイド腫瘍と呼ばれることもあるが、膵臓、肺、その他の部位にもみられる。市場分析と洞察神経内分泌腫瘍治療の世界市場 世界の神経内分泌腫瘍治療市場は、2024年の1億6,320万米ドルから2030年には2億3,030万米ドルに成長すると予測され、予測期間中の年間平均成長率(CAGR)は5.9%である。 世界の医薬品市場は2022年に1,475億米ドルとなり、今後6年間のCAGRは5%で成長する。医薬品市場には化学医薬品と生物学的製剤が含まれる。生物製剤は2022年に3810億米ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間&政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要とする患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の流行はワクチン開発とサプライチェーン・マネジメントの重要性を浮き彫りにし、製薬企業が新たな公衆衛生のニーズに機敏に対応する必要性をさらに強調している。 レポートの対象 本レポートでは、神経内分泌腫瘍治療の世界市場規模について概観します。2019年~2023年の過去の市場収益データ、2024年の推定値、2030年までのCAGR予測による世界市場動向の分析。 神経内分泌腫瘍治療の主要生産者を調査し、主要地域・国の収益も掲載しています。神経内分泌腫瘍治療の今後の市場ポテンシャルと、この市場を様々なセグメントとサブセグメントに予測するための主要地域/国の注目点のハイライト。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データと市場価値分析。 本レポートは、2019年から2024年までのデータで、神経内分泌腫瘍治療の収益、市場シェア、主要企業の業界ランキングに焦点を当てています。世界の神経内分泌腫瘍治療市場における主要な利害関係者を特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。 本レポートでは、2019年から2030年までのタイプ別、用途別のセグメントデータ、収益、成長率を分析しています。神経内分泌腫瘍治療の収益、予測成長動向、生産技術、用途、エンドユーザー産業の市場規模を評価・予測します。 市場区分 企業別 エクセリクシス社 アドバンスト・アクセラレーター・アプリケーション ドーントレス社 ハッチンソン・メディファーマ・リミテッド イスペン ノバルティスAG プロジェニクス・ファーマシューティカルズ社 タルベダ・セラピューティクス タイプ別セグメント エベロリムス スニチニブ Lu-ドタテート ランレオチド オクトレオチド 用途別セグメント 病院 クリニック その他 地域別 北米 米国 カナダ 欧州 ドイツ フランス 英国 イタリア ロシア 北欧諸国 その他の欧州諸国 中国 アジア(中国を除く) 日本 韓国 中国 台湾 東南アジア インド ラテンアメリカ、中東、アフリカ ブラジル メキシコ トルコ イスラエル GCC諸国 各章の概要 第1章:報告書のスコープ、各市場セグメント(製品タイプ、用途など)の市場規模、将来の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と、短期・中期・長期的な展開の可能性について、ハイレベルな見解を提供しています。 第2章 神経内分泌腫瘍治療の世界・地域レベルでの収益各地域とその主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場スペース、生産能力などを紹介しています。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界各社が直面する課題とリスク、業界の関連政策の分析などを紹介します。 第3章:神経内分泌腫瘍治療薬企業の競争環境、収益、市場シェア、業界ランキング、最新の開発計画、合併・買収情報などを詳細に分析。 第4章:タイプ別の様々な市場セグメントの分析を提供し、各市場セグメントの収益、発展の可能性をカバーし、読者が異なる市場セグメントにおけるブルーオーシャン市場を見つけるのに役立ちます。 第5章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの収益、発展の可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。 第6章:北米(米国・カナダ):タイプ別、用途別、国別、セグメント別の収益。 第7章:ヨーロッパ:タイプ別、用途別、国別、セグメント別収益。 第8章:中国:タイプ別、用途別、セグメント別収益。 第9章:アジア(中国を除く):タイプ別、用途別、地域別、各セグメントの収益。 第10章:中東、アフリカ、ラテンアメリカ:タイプ別、用途別、国別、セグメント別収益。 第11章:主要企業のプロフィールを提供し、製品の説明や仕様、神経内分泌腫瘍治療の収益、売上総利益率、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介する。 第12章:アナリストの視点/結論 目次1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Neuroendocrine Tumor Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 1.2.2 Everolimus 1.2.3 Sunitinib 1.2.4 Lu-Dotatate 1.2.5 Lanreotide 1.2.6 Octreotide 1.3 Market by Application 1.3.1 Global Neuroendocrine Tumor Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 1.3.2 Hospitals 1.3.3 Clinic 1.3.4 Others 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Global Growth Trends 2.1 Global Neuroendocrine Tumor Treatment Market Perspective (2019-2030) 2.2 Global Neuroendocrine Tumor Treatment Growth Trends by Region 2.2.1 Neuroendocrine Tumor Treatment Market Size by Region: 2019 VS 2023 VS 2030 2.2.2 Neuroendocrine Tumor Treatment Historic Market Size by Region (2019-2024) 2.2.3 Neuroendocrine Tumor Treatment Forecasted Market Size by Region (2025-2030) 2.3 Neuroendocrine Tumor Treatment Market Dynamics 2.3.1 Neuroendocrine Tumor Treatment Industry Trends 2.3.2 Neuroendocrine Tumor Treatment Market Drivers 2.3.3 Neuroendocrine Tumor Treatment Market Challenges 2.3.4 Neuroendocrine Tumor Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Revenue Neuroendocrine Tumor Treatment by Players 3.1.1 Global Neuroendocrine Tumor Treatment Revenue by Players (2019-2024) 3.1.2 Global Neuroendocrine Tumor Treatment Revenue Market Share by Players (2019-2024) 3.2 Global Neuroendocrine Tumor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Global Key Players of Neuroendocrine Tumor Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024 3.4 Global Neuroendocrine Tumor Treatment Market Concentration Ratio 3.4.1 Global Neuroendocrine Tumor Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Neuroendocrine Tumor Treatment Revenue in 2023 3.5 Global Key Players of Neuroendocrine Tumor Treatment Head office and Area Served 3.6 Global Key Players of Neuroendocrine Tumor Treatment, Product and Application 3.7 Global Key Players of Neuroendocrine Tumor Treatment, Date of Enter into This Industry 3.8 Mergers & Acquisitions, Expansion Plans 4 Neuroendocrine Tumor Treatment Breakdown Data by Type 4.1 Global Neuroendocrine Tumor Treatment Historic Market Size by Type (2019-2024) 4.2 Global Neuroendocrine Tumor Treatment Forecasted Market Size by Type (2025-2030) 5 Neuroendocrine Tumor Treatment Breakdown Data by Application 5.1 Global Neuroendocrine Tumor Treatment Historic Market Size by Application (2019-2024) 5.2 Global Neuroendocrine Tumor Treatment Forecasted Market Size by Application (2025-2030) 6 North America 6.1 North America Neuroendocrine Tumor Treatment Market Size (2019-2030) 6.2 North America Neuroendocrine Tumor Treatment Market Size by Type 6.2.1 North America Neuroendocrine Tumor Treatment Market Size by Type (2019-2024) 6.2.2 North America Neuroendocrine Tumor Treatment Market Size by Type (2025-2030) 6.2.3 North America Neuroendocrine Tumor Treatment Market Share by Type (2019-2030) 6.3 North America Neuroendocrine Tumor Treatment Market Size by Application 6.3.1 North America Neuroendocrine Tumor Treatment Market Size by Application (2019-2024) 6.3.2 North America Neuroendocrine Tumor Treatment Market Size by Application (2025-2030) 6.3.3 North America Neuroendocrine Tumor Treatment Market Share by Application (2019-2030) 6.4 North America Neuroendocrine Tumor Treatment Market Size by Country 6.4.1 North America Neuroendocrine Tumor Treatment Market Size by Country: 2019 VS 2023 VS 2030 6.4.2 North America Neuroendocrine Tumor Treatment Market Size by Country (2019-2024) 6.4.3 North America Neuroendocrine Tumor Treatment Market Size by Country (2025-2030) 6.4.4 U.S. 6.4.5 Canada 7 Europe 7.1 Europe Neuroendocrine Tumor Treatment Market Size (2019-2030) 7.2 Europe Neuroendocrine Tumor Treatment Market Size by Type 7.2.1 Europe Neuroendocrine Tumor Treatment Market Size by Type (2019-2024) 7.2.2 Europe Neuroendocrine Tumor Treatment Market Size by Type (2025-2030) 7.2.3 Europe Neuroendocrine Tumor Treatment Market Share by Type (2019-2030) 7.3 Europe Neuroendocrine Tumor Treatment Market Size by Application 7.3.1 Europe Neuroendocrine Tumor Treatment Market Size by Application (2019-2024) 7.3.2 Europe Neuroendocrine Tumor Treatment Market Size by Application (2025-2030) 7.3.3 Europe Neuroendocrine Tumor Treatment Market Share by Application (2019-2030) 7.4 Europe Neuroendocrine Tumor Treatment Market Size by Country 7.4.1 Europe Neuroendocrine Tumor Treatment Market Size by Country: 2019 VS 2023 VS 2030 7.4.2 Europe Neuroendocrine Tumor Treatment Market Size by Country (2019-2024) 7.4.3 Europe Neuroendocrine Tumor Treatment Market Size by Country (2025-2030) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 China 8.1 China Neuroendocrine Tumor Treatment Market Size (2019-2030) 8.2 China Neuroendocrine Tumor Treatment Market Size by Type 8.2.1 China Neuroendocrine Tumor Treatment Market Size by Type (2019-2024) 8.2.2 China Neuroendocrine Tumor Treatment Market Size by Type (2025-2030) 8.2.3 China Neuroendocrine Tumor Treatment Market Share by Type (2019-2030) 8.3 China Neuroendocrine Tumor Treatment Market Size by Application 8.3.1 China Neuroendocrine Tumor Treatment Market Size by Application (2019-2024) 8.3.2 China Neuroendocrine Tumor Treatment Market Size by Application (2025-2030) 8.3.3 China Neuroendocrine Tumor Treatment Market Share by Application (2019-2030) 9 Asia (excluding China) 9.1 Asia Neuroendocrine Tumor Treatment Market Size (2019-2030) 9.2 Asia Neuroendocrine Tumor Treatment Market Size by Type 9.2.1 Asia Neuroendocrine Tumor Treatment Market Size by Type (2019-2024) 9.2.2 Asia Neuroendocrine Tumor Treatment Market Size by Type (2025-2030) 9.2.3 Asia Neuroendocrine Tumor Treatment Market Share by Type (2019-2030) 9.3 Asia Neuroendocrine Tumor Treatment Market Size by Application 9.3.1 Asia Neuroendocrine Tumor Treatment Market Size by Application (2019-2024) 9.3.2 Asia Neuroendocrine Tumor Treatment Market Size by Application (2025-2030) 9.3.3 Asia Neuroendocrine Tumor Treatment Market Share by Application (2019-2030) 9.4 Asia Neuroendocrine Tumor Treatment Market Size by Region 9.4.1 Asia Neuroendocrine Tumor Treatment Market Size by Region: 2019 VS 2023 VS 2030 9.4.2 Asia Neuroendocrine Tumor Treatment Market Size by Region (2019-2024) 9.4.3 Asia Neuroendocrine Tumor Treatment Market Size by Region (2025-2030) 9.4.4 Japan 9.4.5 South Korea 9.4.6 China Taiwan 9.4.7 Southeast Asia 9.4.8 India 9.4.9 Australia 10 Middle East, Africa, and Latin America 10.1 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size (2019-2030) 10.2 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Type 10.2.1 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Type (2019-2024) 10.2.2 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Type (2025-2030) 10.2.3 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Share by Type (2019-2030) 10.3 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Application 10.3.1 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Application (2019-2024) 10.3.2 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Application (2025-2030) 10.3.3 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Share by Application (2019-2030) 10.4 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Country 10.4.1 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Country: 2019 VS 2023 VS 2030 10.4.2 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Country (2019-2024) 10.4.3 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Country (2025-2030) 10.4.4 Brazil 10.4.5 Mexico 10.4.6 Turkey 10.4.7 Saudi Arabia 10.4.8 Israel 10.4.9 GCC Countries 11 Key Players Profiles 11.1 Exelixis, Inc. 11.1.1 Exelixis, Inc. Company Details 11.1.2 Exelixis, Inc. Business Overview 11.1.3 Exelixis, Inc. Neuroendocrine Tumor Treatment Introduction 11.1.4 Exelixis, Inc. Revenue in Neuroendocrine Tumor Treatment Business (2019-2024) 11.1.5 Exelixis, Inc. Recent Developments 11.2 Advanced Accelerator Applications 11.2.1 Advanced Accelerator Applications Company Details 11.2.2 Advanced Accelerator Applications Business Overview 11.2.3 Advanced Accelerator Applications Neuroendocrine Tumor Treatment Introduction 11.2.4 Advanced Accelerator Applications Revenue in Neuroendocrine Tumor Treatment Business (2019-2024) 11.2.5 Advanced Accelerator Applications Recent Developments 11.3 Dauntless Pharmaceuticals, Inc. 11.3.1 Dauntless Pharmaceuticals, Inc. Company Details 11.3.2 Dauntless Pharmaceuticals, Inc. Business Overview 11.3.3 Dauntless Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Introduction 11.3.4 Dauntless Pharmaceuticals, Inc. Revenue in Neuroendocrine Tumor Treatment Business (2019-2024) 11.3.5 Dauntless Pharmaceuticals, Inc. Recent Developments 11.4 Hutchinson Medipharma Limited 11.4.1 Hutchinson Medipharma Limited Company Details 11.4.2 Hutchinson Medipharma Limited Business Overview 11.4.3 Hutchinson Medipharma Limited Neuroendocrine Tumor Treatment Introduction 11.4.4 Hutchinson Medipharma Limited Revenue in Neuroendocrine Tumor Treatment Business (2019-2024) 11.4.5 Hutchinson Medipharma Limited Recent Developments 11.5 Ispen 11.5.1 Ispen Company Details 11.5.2 Ispen Business Overview 11.5.3 Ispen Neuroendocrine Tumor Treatment Introduction 11.5.4 Ispen Revenue in Neuroendocrine Tumor Treatment Business (2019-2024) 11.5.5 Ispen Recent Developments 11.6 Novartis AG 11.6.1 Novartis AG Company Details 11.6.2 Novartis AG Business Overview 11.6.3 Novartis AG Neuroendocrine Tumor Treatment Introduction 11.6.4 Novartis AG Revenue in Neuroendocrine Tumor Treatment Business (2019-2024) 11.6.5 Novartis AG Recent Developments 11.7 Progenics Pharmaceuticals, Inc. 11.7.1 Progenics Pharmaceuticals, Inc. Company Details 11.7.2 Progenics Pharmaceuticals, Inc. Business Overview 11.7.3 Progenics Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Introduction 11.7.4 Progenics Pharmaceuticals, Inc. Revenue in Neuroendocrine Tumor Treatment Business (2019-2024) 11.7.5 Progenics Pharmaceuticals, Inc. Recent Developments 11.8 Tarveda Therapeutics 11.8.1 Tarveda Therapeutics Company Details 11.8.2 Tarveda Therapeutics Business Overview 11.8.3 Tarveda Therapeutics Neuroendocrine Tumor Treatment Introduction 11.8.4 Tarveda Therapeutics Revenue in Neuroendocrine Tumor Treatment Business (2019-2024) 11.8.5 Tarveda Therapeutics Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
SummaryNeuroendocrine tumors (NETs) are neoplasms that arise from cells of the endocrine (hormonal) and nervous systems. Many are benign, while some are malignant. They most commonly occur in the intestine, where they are often called carcinoid tumors, but they are also found in the pancreas, lung and the rest of the body. Table of Contents1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Neuroendocrine Tumor Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 1.2.2 Everolimus 1.2.3 Sunitinib 1.2.4 Lu-Dotatate 1.2.5 Lanreotide 1.2.6 Octreotide 1.3 Market by Application 1.3.1 Global Neuroendocrine Tumor Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 1.3.2 Hospitals 1.3.3 Clinic 1.3.4 Others 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Global Growth Trends 2.1 Global Neuroendocrine Tumor Treatment Market Perspective (2019-2030) 2.2 Global Neuroendocrine Tumor Treatment Growth Trends by Region 2.2.1 Neuroendocrine Tumor Treatment Market Size by Region: 2019 VS 2023 VS 2030 2.2.2 Neuroendocrine Tumor Treatment Historic Market Size by Region (2019-2024) 2.2.3 Neuroendocrine Tumor Treatment Forecasted Market Size by Region (2025-2030) 2.3 Neuroendocrine Tumor Treatment Market Dynamics 2.3.1 Neuroendocrine Tumor Treatment Industry Trends 2.3.2 Neuroendocrine Tumor Treatment Market Drivers 2.3.3 Neuroendocrine Tumor Treatment Market Challenges 2.3.4 Neuroendocrine Tumor Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Revenue Neuroendocrine Tumor Treatment by Players 3.1.1 Global Neuroendocrine Tumor Treatment Revenue by Players (2019-2024) 3.1.2 Global Neuroendocrine Tumor Treatment Revenue Market Share by Players (2019-2024) 3.2 Global Neuroendocrine Tumor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Global Key Players of Neuroendocrine Tumor Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024 3.4 Global Neuroendocrine Tumor Treatment Market Concentration Ratio 3.4.1 Global Neuroendocrine Tumor Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Neuroendocrine Tumor Treatment Revenue in 2023 3.5 Global Key Players of Neuroendocrine Tumor Treatment Head office and Area Served 3.6 Global Key Players of Neuroendocrine Tumor Treatment, Product and Application 3.7 Global Key Players of Neuroendocrine Tumor Treatment, Date of Enter into This Industry 3.8 Mergers & Acquisitions, Expansion Plans 4 Neuroendocrine Tumor Treatment Breakdown Data by Type 4.1 Global Neuroendocrine Tumor Treatment Historic Market Size by Type (2019-2024) 4.2 Global Neuroendocrine Tumor Treatment Forecasted Market Size by Type (2025-2030) 5 Neuroendocrine Tumor Treatment Breakdown Data by Application 5.1 Global Neuroendocrine Tumor Treatment Historic Market Size by Application (2019-2024) 5.2 Global Neuroendocrine Tumor Treatment Forecasted Market Size by Application (2025-2030) 6 North America 6.1 North America Neuroendocrine Tumor Treatment Market Size (2019-2030) 6.2 North America Neuroendocrine Tumor Treatment Market Size by Type 6.2.1 North America Neuroendocrine Tumor Treatment Market Size by Type (2019-2024) 6.2.2 North America Neuroendocrine Tumor Treatment Market Size by Type (2025-2030) 6.2.3 North America Neuroendocrine Tumor Treatment Market Share by Type (2019-2030) 6.3 North America Neuroendocrine Tumor Treatment Market Size by Application 6.3.1 North America Neuroendocrine Tumor Treatment Market Size by Application (2019-2024) 6.3.2 North America Neuroendocrine Tumor Treatment Market Size by Application (2025-2030) 6.3.3 North America Neuroendocrine Tumor Treatment Market Share by Application (2019-2030) 6.4 North America Neuroendocrine Tumor Treatment Market Size by Country 6.4.1 North America Neuroendocrine Tumor Treatment Market Size by Country: 2019 VS 2023 VS 2030 6.4.2 North America Neuroendocrine Tumor Treatment Market Size by Country (2019-2024) 6.4.3 North America Neuroendocrine Tumor Treatment Market Size by Country (2025-2030) 6.4.4 U.S. 6.4.5 Canada 7 Europe 7.1 Europe Neuroendocrine Tumor Treatment Market Size (2019-2030) 7.2 Europe Neuroendocrine Tumor Treatment Market Size by Type 7.2.1 Europe Neuroendocrine Tumor Treatment Market Size by Type (2019-2024) 7.2.2 Europe Neuroendocrine Tumor Treatment Market Size by Type (2025-2030) 7.2.3 Europe Neuroendocrine Tumor Treatment Market Share by Type (2019-2030) 7.3 Europe Neuroendocrine Tumor Treatment Market Size by Application 7.3.1 Europe Neuroendocrine Tumor Treatment Market Size by Application (2019-2024) 7.3.2 Europe Neuroendocrine Tumor Treatment Market Size by Application (2025-2030) 7.3.3 Europe Neuroendocrine Tumor Treatment Market Share by Application (2019-2030) 7.4 Europe Neuroendocrine Tumor Treatment Market Size by Country 7.4.1 Europe Neuroendocrine Tumor Treatment Market Size by Country: 2019 VS 2023 VS 2030 7.4.2 Europe Neuroendocrine Tumor Treatment Market Size by Country (2019-2024) 7.4.3 Europe Neuroendocrine Tumor Treatment Market Size by Country (2025-2030) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 China 8.1 China Neuroendocrine Tumor Treatment Market Size (2019-2030) 8.2 China Neuroendocrine Tumor Treatment Market Size by Type 8.2.1 China Neuroendocrine Tumor Treatment Market Size by Type (2019-2024) 8.2.2 China Neuroendocrine Tumor Treatment Market Size by Type (2025-2030) 8.2.3 China Neuroendocrine Tumor Treatment Market Share by Type (2019-2030) 8.3 China Neuroendocrine Tumor Treatment Market Size by Application 8.3.1 China Neuroendocrine Tumor Treatment Market Size by Application (2019-2024) 8.3.2 China Neuroendocrine Tumor Treatment Market Size by Application (2025-2030) 8.3.3 China Neuroendocrine Tumor Treatment Market Share by Application (2019-2030) 9 Asia (excluding China) 9.1 Asia Neuroendocrine Tumor Treatment Market Size (2019-2030) 9.2 Asia Neuroendocrine Tumor Treatment Market Size by Type 9.2.1 Asia Neuroendocrine Tumor Treatment Market Size by Type (2019-2024) 9.2.2 Asia Neuroendocrine Tumor Treatment Market Size by Type (2025-2030) 9.2.3 Asia Neuroendocrine Tumor Treatment Market Share by Type (2019-2030) 9.3 Asia Neuroendocrine Tumor Treatment Market Size by Application 9.3.1 Asia Neuroendocrine Tumor Treatment Market Size by Application (2019-2024) 9.3.2 Asia Neuroendocrine Tumor Treatment Market Size by Application (2025-2030) 9.3.3 Asia Neuroendocrine Tumor Treatment Market Share by Application (2019-2030) 9.4 Asia Neuroendocrine Tumor Treatment Market Size by Region 9.4.1 Asia Neuroendocrine Tumor Treatment Market Size by Region: 2019 VS 2023 VS 2030 9.4.2 Asia Neuroendocrine Tumor Treatment Market Size by Region (2019-2024) 9.4.3 Asia Neuroendocrine Tumor Treatment Market Size by Region (2025-2030) 9.4.4 Japan 9.4.5 South Korea 9.4.6 China Taiwan 9.4.7 Southeast Asia 9.4.8 India 9.4.9 Australia 10 Middle East, Africa, and Latin America 10.1 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size (2019-2030) 10.2 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Type 10.2.1 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Type (2019-2024) 10.2.2 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Type (2025-2030) 10.2.3 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Share by Type (2019-2030) 10.3 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Application 10.3.1 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Application (2019-2024) 10.3.2 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Application (2025-2030) 10.3.3 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Share by Application (2019-2030) 10.4 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Country 10.4.1 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Country: 2019 VS 2023 VS 2030 10.4.2 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Country (2019-2024) 10.4.3 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Country (2025-2030) 10.4.4 Brazil 10.4.5 Mexico 10.4.6 Turkey 10.4.7 Saudi Arabia 10.4.8 Israel 10.4.9 GCC Countries 11 Key Players Profiles 11.1 Exelixis, Inc. 11.1.1 Exelixis, Inc. Company Details 11.1.2 Exelixis, Inc. Business Overview 11.1.3 Exelixis, Inc. Neuroendocrine Tumor Treatment Introduction 11.1.4 Exelixis, Inc. Revenue in Neuroendocrine Tumor Treatment Business (2019-2024) 11.1.5 Exelixis, Inc. Recent Developments 11.2 Advanced Accelerator Applications 11.2.1 Advanced Accelerator Applications Company Details 11.2.2 Advanced Accelerator Applications Business Overview 11.2.3 Advanced Accelerator Applications Neuroendocrine Tumor Treatment Introduction 11.2.4 Advanced Accelerator Applications Revenue in Neuroendocrine Tumor Treatment Business (2019-2024) 11.2.5 Advanced Accelerator Applications Recent Developments 11.3 Dauntless Pharmaceuticals, Inc. 11.3.1 Dauntless Pharmaceuticals, Inc. Company Details 11.3.2 Dauntless Pharmaceuticals, Inc. Business Overview 11.3.3 Dauntless Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Introduction 11.3.4 Dauntless Pharmaceuticals, Inc. Revenue in Neuroendocrine Tumor Treatment Business (2019-2024) 11.3.5 Dauntless Pharmaceuticals, Inc. Recent Developments 11.4 Hutchinson Medipharma Limited 11.4.1 Hutchinson Medipharma Limited Company Details 11.4.2 Hutchinson Medipharma Limited Business Overview 11.4.3 Hutchinson Medipharma Limited Neuroendocrine Tumor Treatment Introduction 11.4.4 Hutchinson Medipharma Limited Revenue in Neuroendocrine Tumor Treatment Business (2019-2024) 11.4.5 Hutchinson Medipharma Limited Recent Developments 11.5 Ispen 11.5.1 Ispen Company Details 11.5.2 Ispen Business Overview 11.5.3 Ispen Neuroendocrine Tumor Treatment Introduction 11.5.4 Ispen Revenue in Neuroendocrine Tumor Treatment Business (2019-2024) 11.5.5 Ispen Recent Developments 11.6 Novartis AG 11.6.1 Novartis AG Company Details 11.6.2 Novartis AG Business Overview 11.6.3 Novartis AG Neuroendocrine Tumor Treatment Introduction 11.6.4 Novartis AG Revenue in Neuroendocrine Tumor Treatment Business (2019-2024) 11.6.5 Novartis AG Recent Developments 11.7 Progenics Pharmaceuticals, Inc. 11.7.1 Progenics Pharmaceuticals, Inc. Company Details 11.7.2 Progenics Pharmaceuticals, Inc. Business Overview 11.7.3 Progenics Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Introduction 11.7.4 Progenics Pharmaceuticals, Inc. Revenue in Neuroendocrine Tumor Treatment Business (2019-2024) 11.7.5 Progenics Pharmaceuticals, Inc. Recent Developments 11.8 Tarveda Therapeutics 11.8.1 Tarveda Therapeutics Company Details 11.8.2 Tarveda Therapeutics Business Overview 11.8.3 Tarveda Therapeutics Neuroendocrine Tumor Treatment Introduction 11.8.4 Tarveda Therapeutics Revenue in Neuroendocrine Tumor Treatment Business (2019-2024) 11.8.5 Tarveda Therapeutics Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
QYResearch社の医療分野での最新刊レポート
本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |